Skip to menu Skip to content Skip to footer
Professor Mark Smithers
Professor

Mark Smithers

Email: 

Overview

Background

Emeritus Professor Mark Smithers is a surgical oncologist who specialises in surgery for oesophago-gastric diseases, melanoma, advanced skin cancer and soft tissue sarcoma. He was the Director of the Upper GI and Soft Tissue Unit at the Princess Alexandra Hospital, in Brisbane, Australia from 1998 - 2023. Commencing his academic career with the University of Queensland in 1987, he progressed to be the Mayne Chair in Surgery and head of the Academy of Surgery. He is the second University of Queensland Medical graduate to be appointed to this role. His research has been focussed on the development and assessment of outcomes from minimally invasive upper GI surgery, and trials assessing the role of perioperative multidisciplinary therapy for esophageal and gastric cancer. As well he has led, or been involved with, clinical trials from phase I to III, for all stages of melanoma through his role as the Chair of the Queensland Melanoma Project. More recently he has been involved with the assessment of access to, and outcomes from, surgery for cancer in Queensland, Australia.

He has overseen the administration and development of the surgery curriculum, and the teaching, in the Academy of Surgery, in the UQ Faculty of Medicine. He was on a number of committees relevant to the implementation of the UQ MD design course. He has held various leadership and committee roles with the Royal Australasian College of Surgeons, as well as leadership roles, including the Presidency, in the Australian and New Zealand Oesophago Gastric Surgeons Association. He has also been on the committees of international organisations related to oesophageal and gastric surgery. He has published 250 articles, eight book chapters, and has been on the editorial board of a number of surgical journals.

He has been recognised for his clinical and academic roles by the award of Member of the Order of Australia (AM). The citation reads, "for service to medicine in the fields of gastro-intestinal and melanoma surgery, to medical education and to professional organisations". The Royal Australasian College of Surgeons awarded him the Sir Hugh Devine medal, for services to surgery and the community. This is the College’s highest honour. Internationally, he has been awarded an honorary fellowship of the Royal College of Surgeons of Edinburgh and recently, in the United States, he was elected as an Honarary Fellow of the American Surgical Association.

Availability

Professor Mark Smithers is:
Not available for supervision
Media expert

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Honorary Fellow, American Surgical Association, American Surgical Association
  • Fellow, Royal Australasian College of Surgeons, Royal Australasian College of Surgeons
  • Fellow, Royal College of Surgeons of Edinburgh, Royal College of Surgeons of Edinburgh
  • Fellow, Royal College of Surgeons of England, Royal College of Surgeons of England

Research interests

  • Cutaneous Melanoma

    epidemiology, public health issues and management of all stages

  • Management of Oesophageal and Gastric Cancer

    Investigation and management of benign and malignant diseases of the oesophagus and the stomach.

Works

Search Professor Mark Smithers’s works on UQ eSpace

410 works between 1983 and 2025

101 - 120 of 410 works

2019

Journal Article

Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy

van Hootegem, S. J. M., Smithers, B. M., Gotley, D. C., Brosda, S., Thomson, I. G., Thomas, J. M., Gartside, M. and Barbour, A. P. (2019). Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy. Diseases of the Esophagus, 33 (6) doz082. doi: 10.1093/dote/doz082

Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy

2019

Journal Article

Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”

Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, Peter H. and Smithers, Mark B. (2019). Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”. Journal of Surgical Oncology, 120 (6), 1058-1059. doi: 10.1002/jso.25686

Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”

2019

Conference Publication

An international randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck

Foote, Matthew, Smithers, Mark, Hong, Angela, Fogarty, Gerald, Scolyer, Richard, Paton, Elizabeth, Barker, Christopher, Chua, Margaret, Shannon, Kerwin, Burmeister, Bryan, Nobes, Jenny and Williams, Narelle (2019). An international randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck. HOBOKEN: WILEY.

An international randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck

2019

Journal Article

Assessment of hospital characteristics associated with improved mortality following complex upper gastrointestinal cancer surgery in Queensland

Narendra, Aaditya, Baade, Peter D., Aitken, Joanne F., Fawcett, Jonathan and Smithers, Bernard M. (2019). Assessment of hospital characteristics associated with improved mortality following complex upper gastrointestinal cancer surgery in Queensland. ANZ Journal of Surgery, 89 (11), 1404-1409. doi: 10.1111/ans.15389

Assessment of hospital characteristics associated with improved mortality following complex upper gastrointestinal cancer surgery in Queensland

2019

Conference Publication

A randomised, double-blind, placebo-controlled, multi-institutional phase II study of adjuvant anti-PD-1 in patients with stage I-III Merkel cell carcinoma [I-MAT study]

Xu, Wen, Poulsen, Michael, Atkinson, Victoria, Fogarty, Gerald, Veness, Michael, Smithers, Bernard, Gyorki, David, Mar, Victoria, Howle, Julie, Guminski, Alexander, Williams, Narelle and Paton, Elizabeth (2019). A randomised, double-blind, placebo-controlled, multi-institutional phase II study of adjuvant anti-PD-1 in patients with stage I-III Merkel cell carcinoma [I-MAT study]. HOBOKEN: WILEY.

A randomised, double-blind, placebo-controlled, multi-institutional phase II study of adjuvant anti-PD-1 in patients with stage I-III Merkel cell carcinoma [I-MAT study]

2019

Journal Article

New treatment paradigms for clinically apparent metastatic melanoma in regional lymph nodes

Henderson, Michael A., Spillane, John, Hughes, T. Michael, Spillane, Andrew J., Smithers, B. Mark and Thompson, John F. (2019). New treatment paradigms for clinically apparent metastatic melanoma in regional lymph nodes. ANZ Journal of Surgery, 89 (10), 1187-1189. doi: 10.1111/ans.15407

New treatment paradigms for clinically apparent metastatic melanoma in regional lymph nodes

2019

Journal Article

Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma

Claeson, M., Baade, P., Brown, S., Soyer, H. P., Smithers, B. M., Green, A. C., Whiteman, D. C. and Khosrotehrani, K. (2019). Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma. British Journal of Dermatology, 182 (4) bjd.18560, 927-931. doi: 10.1111/bjd.18560

Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma

2019

Journal Article

The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinoma

van Hootegem, Sander J. M., Smithers, B. Mark, Gotley, David C., Brosda, Sandra, Thomson, Iain G., Thomas, Janine M., Gartside, Michael, van Lanschot, Jan J. B., Lagarde, Sjoerd M., Wijnhoven, Bas P. L. and Barbour, Andrew P. (2019). The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinoma. Annals of Surgical Oncology, 26 (8), 2375-2384. doi: 10.1245/s10434-019-07322-x

The impact of signet ring cell differentiation on outcome in patients with esophageal and gastroesophageal junction adenocarcinoma

2019

Journal Article

IRF4 rs12203592*T/T genotype is associated with nodular melanoma

Rayner, Jenna E., McMeniman, Erin K., Duffy, David L., De'Ambrosis, Brian, Smithers, B Mark, Jagirdar, Kasturee, Lee, Katie J., Soyer, H Peter and Sturm, Richard A. (2019). IRF4 rs12203592*T/T genotype is associated with nodular melanoma. Melanoma Research, 29 (4), 445-446. doi: 10.1097/CMR.0000000000000596

IRF4 rs12203592*T/T genotype is associated with nodular melanoma

2019

Journal Article

Multidisciplinary cancer care in Australia

Walpole, Euan, Smithers, Mark, Cossio, Danica, Harden, Hazel, Thiele, David and Janda, Monika (2019). Multidisciplinary cancer care in Australia. Asia-Pacific Journal of Clinical Oncology, 15 (4), 197-198. doi: 10.1111/ajco.13164

Multidisciplinary cancer care in Australia

2019

Journal Article

Future is bright for academic surgery in Australasia: highlights of the 2018 Academic Meetings

Lee, James C., Mukherjee, Payal, Koh, Cherry and Smithers, Mark (2019). Future is bright for academic surgery in Australasia: highlights of the 2018 Academic Meetings. ANZ Journal of Surgery, 89 (7-8), 798-799. doi: 10.1111/ans.15341

Future is bright for academic surgery in Australasia: highlights of the 2018 Academic Meetings

2019

Journal Article

Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients

Rayner, J. E., McMeniman, E. K., Duffy, D. L., De'Ambrosis, B., Smithers, B. M., Jagirdar, K., Lee, K. J., Soyer, H. P. and Sturm, R. A. (2019). Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients. Journal of the European Academy of Dermatology and Venereology, 33 (6) jdv.15446, 1076-1083. doi: 10.1111/jdv.15446

Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients

2019

Journal Article

Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study

Kroon, Hidde M., Coventry, Brendon J., Henderson, Michael A., Barbour, Andrew, Serpell, Jonathan, Smithers, B. Mark and Thompson, John F. (2019). Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study. European Journal of Surgical Oncology, 45 (5), 832-837. doi: 10.1016/j.ejso.2019.02.026

Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: an Australian multi-center study

2019

Journal Article

Risk of melanoma recurrence after diagnosis of a high-risk primary tumor

Von Schuckmann, Lena A., Hughes, Maria Celia B., Ghiasvand, Reza, Malt, Maryrose, Van Der Pols, Jolieke C., Beesley, Vanessa L., Khosrotehrani, Kiarash, Smithers, B. Mark and Green, Adele C. (2019). Risk of melanoma recurrence after diagnosis of a high-risk primary tumor. JAMA Dermatology, 155 (6), 688-693. doi: 10.1001/jamadermatol.2019.0440

Risk of melanoma recurrence after diagnosis of a high-risk primary tumor

2019

Conference Publication

ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck

Foote, M., Smithers, M., Hong, A., Fogarty, G., Scolyer, R., Paton, E., Barker, C., Chua, M., Shannon, K., Burmeister, B. and Nobes, J. (2019). ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck. HOBOKEN: WILEY.

ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck

2019

Journal Article

Conclusions from quality of life studies in patients with resected high-risk melanoma: one part of the full story

Smithers, B. Mark (2019). Conclusions from quality of life studies in patients with resected high-risk melanoma: one part of the full story. The Lancet Oncology, 20 (5), 611-612. doi: 10.1016/S1470-2045(19)30176-7

Conclusions from quality of life studies in patients with resected high-risk melanoma: one part of the full story

2019

Journal Article

Long–term oncologic outcomes after isolated limb infusion for locoregionally metastatic melanoma: an international multicenter analysis

Miura, John T., Kroon, Hidde M., Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Kim, Youngchul, Naqvi, Syeda Mahrukh Hussnain, Potdar, Aishwarya, Daou, Hala, Sun, James, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Smithers, B. Mark , Coventry, Brendon J., Tyler, Douglas S., Thompson, John F. and Zager, Jonathan S. (2019). Long–term oncologic outcomes after isolated limb infusion for locoregionally metastatic melanoma: an international multicenter analysis. Annals of Surgical Oncology, 26 (8), 2486-2494. doi: 10.1245/s10434-019-07288-w

Long–term oncologic outcomes after isolated limb infusion for locoregionally metastatic melanoma: an international multicenter analysis

2019

Journal Article

Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus

Atay, Scott M., Correa, Arlene, Hofstetter, Wayne L., Swisher, Stephen G., Ajani, Jaffer, Altorki, Nassar K., Blackmon, Shanda H., Blackstone, Eugene H., Rice, Thomas W., Crabtree, Traves D., D'Amico, Thomas A., Darling, Gail E., DeMeester, Steven R., DeMeester, Thomas R., Worrell, Stephanie G., Ferri, Lorenzo E., Gaissert, Henning A., Krasna, Mark J., Lerut, Antoon, Nafteux, Phillippe, Moons, Johnny, Little, Alex G., Low, Donald E., Carrott, Phillip W., Schmidt, Henner M., Miller, Daniel, Nason, Katie S., Luketich, James D., Orringer, Mark B. ... Yang, Stephen C. (2019). Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus. Journal of Thoracic and Cardiovascular Surgery, 157 (3), 1264-1272.e6. doi: 10.1016/j.jtcvs.2018.10.057

Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus

2019

Journal Article

A systematic review and meta-analysis of locoregional treatments for in-transit melanoma

Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2019). A systematic review and meta-analysis of locoregional treatments for in-transit melanoma. Journal of Surgical Oncology, 119 (7) jso.25686, 887-896. doi: 10.1002/jso.25400

A systematic review and meta-analysis of locoregional treatments for in-transit melanoma

2019

Conference Publication

Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-I

Rand, J. G., Kirchoff, D., Deutsch, G., Stern, S., Thompson, J., Cochran, A., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Sondak, V., Coventry, B., Kashani-Sabet, M., Smithers, M., Paul, E., Kraybill, W., Elashoff, R., Lee, D. and Faries, M. B. (2019). Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-I. 72nd Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO), San Diego Ca, Mar 27-30, 2019. NEW YORK: SPRINGER.

Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-I

Supervision

Availability

Professor Mark Smithers is:
Not available for supervision

Supervision history

Current supervision

  • Master Philosophy

    Retroperitoneal sarcoma: Impact of the patterns of care on patient outcomes in Queensland.

    Principal Advisor

    Other advisors: Professor Andrew Barbour

  • Master Philosophy

    Trends in the regional nodal management of cutaneous melanoma.

    Principal Advisor

    Other advisors: Professor Peter Soyer

  • Master Philosophy

    Factors Influencing Anastomotic Complications after Oesophagectomy

    Associate Advisor

  • Doctor Philosophy

    Utilising the Multi-Disciplinary Resources at Tertiary Centres to Improve Outcomes from Pancreatic Cancer

    Associate Advisor

    Other advisors: Dr David Cavallucci

Completed supervision

Media

Enquiries

Contact Professor Mark Smithers directly for media enquiries about:

  • Advanced endoscopic surgery
  • Cancer surgery
  • Endoscopic surgery
  • General surgery
  • Melanoma
  • Surgery - cancer
  • Surgery - oesophageal, gastric cancer
  • Surgery - upper GI
  • Upper GI surgery

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au